THE TREATMENT OF ATOPIC DERMATITIS IN CHILDREN: POSSIBLE CAUSES OF DISEASE PROGRESSION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Atopic dermatitis is a chronic continuously recurrent skin disease with early onset. Nowadays the pathogenesis of many local inflammatory processes is studied rather well and diagnostic and treatment techniques are thoroughly worked out. However, in a number of cases the disease still progresses: the periods of short remission are followed by flare-ups. Why do we sometimes fail to induce long-lasing remission? What causes severe AD? We have tried to answer these and some other questions by analyzing recommended and applied treatment methods and employing Russian and foreign professional publications. We have proved that anti-relapse therapy supported with the usage of cosmetics gives assurance in AD effective treatment.

全文:

受限制的访问

作者简介

A. Kudryavtseva

I.M. Sechenov First Moscow State Medical University

Email: scientist002@yahoo.com

A. Mingaliev

I.M. Sechenov First Moscow State Medical University

Email: scientist002@yahoo.com

E. Neskorodova

I.M. Sechenov First Moscow State Medical University

Email: scientist002@yahoo.com

参考

  1. Перламутров Ю.Н., Ключникова Д.Е. Особенности течения атопического дерматита у детей, постоянно проживающих в условиях антопогенного загрязнения // Вестн. дерматол. венерол. - 2011; 5: 102-7.
  2. Burrenl-Morris C., Williams H. Atopic dermatitis in migrant population. Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema / Cambridge, MA, 2000; 228 p.
  3. Кудрявцева А.В., Макарова С.Г. Случай тяжелого течения атопического дерматита у ребенка раннего возраста // Вопр. практич. педиатрии. - 2010; 4 (5): 18-21.
  4. Bikowski J., Pillai R., Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects // J. Drugs Dermatol. - 2006; 5 (2): 125-30.
  5. Pallen A., Lebwohl M., Fleischer A. et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies // J. Am. Acad. Dermatol. - 2005; 52 (5): 810-22.
  6. Sidbury R., Davis D., Cohen D. et al. Guidelines of care for the management of atopic dermatitis: section 2 and 3. Management and treatment of atopic dermatitis with topical therapies. Management and treatment with phototherapy and systemic agents // J. Am. Acad. Dermatol. - 2014; 71 (1, 2): 327-49.
  7. Hung S., Lin Y., Chu C. et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics // Ann. Allergy Asthma Immunol. - 2007; 98 (1): 51-6.
  8. Атопический дерматит у детей: диагностика, лечение и профилактика: Научно-практич. программа / М., 2000; 76 с.
  9. Wahlgren C., Hagermark O., Bergstrom R. The antipruritis effect of a sedative and a non-sedative antihistamine in atopic dermatitis // Br. J. Dermatol. - 1990; 122: 545-51.
  10. Greene R., Winkermann R. Opfer-Gehrking T. Sweeting patterns in atopic dermatitis patients // Arch. Dermatol. Res. - 1989; 281: 373-6.
  11. Soncoly E., Muller A., Lauerma A. et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation // J. Allergy Clin. Immunol. - 2006; 117: 411-7.
  12. Торопина Г.Г., Юдина М.М., Львов А.Н. и др. Нейрофизиологические механизмы зуда при атопическом дерматите: исследование длиннолатентных вызванных потенциалов на термическую стимуляцию тонких волокон // Рос. журн. кожных и венерических болезней. - 2008; 4: 18-22.
  13. Миченко А.В., Львов А.Н., Иванов О.Л. и др. Психосоматические аспекты атопического дерматита: классические каноны и новые представления // Рос. журн. кожных и венерических болезней. - 2008; 4: 11-8.
  14. Yoshihara K. Psychosomatic treatment for allergic diseases // Biopsychosoc. Med. - 2015; 18 (9): 8.
  15. Warner J. ETAC Study Group. A double-blinded, randomized, placebocontrolled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months'treatment and 18 months' posttreatment follow-up // J. Allergy Clin. Immunol. - 2001; 108: 929-37.
  16. Кудрявцева А.В., Возможности терапии тяжелых форм атопического дерматита у детей и подростков // Вопр. практич. педиатрии. - 2011; 6 (6): 51-6.
  17. Кочергин Н.Г., Потекаев Н.С. Циклоспорин А при атопическом дерматите / М., 1999; 24 с.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2022
##common.cookie##